Market Tracker

02/19 8:31am ET

Melinta Therapeutics, Inc. (NASDAQ:MLNT)

13.00
Delayed Data
As of Feb 16
 -0.20 / -1.52%
Today’s Change
10.25
Today|||52-Week Range
24.25
-17.72%
Year-to-Date
No recent news for Melinta Therapeutics, Inc..

Today’s Trading

Previous close13.20
Today’s open13.40
Day’s range12.75 - 13.40
Volume99,880
Average volume (3 months)148,419
Market cap$407.2M
Data as of 4:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)-11.96%
Earnings growth (this year)+60.09%
Earnings growth (next 5 years)--
Revenue growth (last year)-34.03%
P/E ratioNM
Price/Sales7.82
Price/Book0.74

Competitors

 Today’s
change
Today’s
% change
SMMTSummit Therapeutics ...-0.50-4.11%
VRNAVerona Pharma PLC+0.05+0.39%
NTECIntec Pharma Ltd-0.08-1.30%
ACRXAcelRx Pharmaceutica...+0.15+8.57%
Data as of 4:00pm ET, 02/16/2018

Financials

Next reporting dateMarch 1, 2018
EPS forecast (this quarter)-$0.86
Annual revenue (last year)$18.0M
Annual profit (last year)-$118.0M
Net profit margin-654.76%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Daniel Mark Wechsler
Chief Financial Officer, Secretary &
EVP
Paul Estrem
Corporate headquarters
New Haven, Connecticut

Forecasts